With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Genetic Analysis of Pediatric Gliomas||Baylor College of Medicine / Will Parsons, MD, PhD||'A' Award Grants||2009||Texas|
|Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies||Baylor College of Medicine / Stephen Gottschalk, MD||Innovation Grants||2013||Texas|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|
|Pediatric Sarcoma, Rhabdomyosarcoma, and Mechanisms of Origin||University of Texas Southwestern Medical Center / Rene Galindo||'A' Award Grants||2010||Texas|
|Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence||Baylor College of Medicine / Stacey Berg, MD - Scholars: Jennifer Foster, MD, MPH and Ron Bernardi, MD,PhD||Center of Excellence Grants||2012||Texas|
|Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity||University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD||Innovation Grants||2018||Texas|
|DICER1-Driven Cancers: Models, Mechanisms and Therapies||University of Texas Southwestern Medical Center at Dallas / James Amatruda, MD/PhD||Innovation Grants||2016||Texas|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|
|Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide||University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD||Young Investigator Grants||2008||Texas|
|Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma||Baylor College of Medicine / Jason Yustein, MD/PhD||Innovation Grants||2018||Texas|